MedTrace Logo

Platelet Enriched Plasma for Treatment of Interstitial Cystitis

NCT04118946 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2019-10-08

No results posted yet for this study

Summary

A prospective randomized trial will be conducted aiming at evaluation the efficacy and safety of platelet enriched plasma for management of bladder pain syndrome .

Conditions

  • Interstitial Cystitis
  • Bladder Pain Syndrome
  • Platelet Enriched Plasma

Interventions

BIOLOGICAL

platelet enriched plasma

PRP is prepared via a two-step centrifugation preparation of a blood sample, which is cured with an anticoagulant. Then either with be applied through urethral catheter in one arm or via submucos injection in anther one.

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmed El Hefnawy, Msc, MD · Assistant professor of urology .Mansoura Urology and Nephrology Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-20
Primary Completion
2020-06-30
Completion
2020-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04118946 on ClinicalTrials.gov